Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours
Author(s)
Type
Journal Article
Abstract
Correction to: British Journal of Cancer (2018) 118, 156–167; doi: 10.1038/bjc.2017.327; published online 26 September 2017.
There was an error in the description of the pharmacodynamics within the ‘Materials and methods’ section of this manuscript, and with the reference cited Printz et al (2017). The correct description is shown below:
There was an error in the description of the pharmacodynamics within the ‘Materials and methods’ section of this manuscript, and with the reference cited Printz et al (2017). The correct description is shown below:
Date Issued
2018-01-23
Date Acceptance
2018-01-01
Citation
British Journal of Cancer, 2018, 118
ISSN
0007-0920
Publisher
Cancer Research UK
Journal / Book Title
British Journal of Cancer
Volume
118
Copyright Statement
© 2018 The Author(s). This work is licensed under the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423184900003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
Publication Status
Published
Article Number
e3
Date Publish Online
2018-01-23